21.38
                                            Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)
Gewinn- und Verlustrechnung
                
            Vierteljährlich
                
            
        *Alle Zahlen in Millionen
    
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 
| Revenues | 
                                            
                                        7.21%
                                     181.10 | 168.92 | 168.57 | 178.02 | 167.12 | 
| Cost Of Revenue | 
                                            
                                        19.12%
                                     40.87 | 34.31 | 38.86 | 44.26 | 47.42 | 
| Gross Profit | 
                                            
                                        4.17%
                                     140.23 | 134.62 | 129.71 | 133.76 | 119.70 | 
|  | 
                                            
                                        0.67%
                                     131.73 | 132.63 | 269.24 | 105.52 | 106.49 | 
| Benefits Costs and Expenses | 
                                            
                                        14.24%
                                     183.03 | 160.22 | 307.43 | 141.44 | 153.48 | 
| Costs And Expenses | 
                                            
                                        3.39%
                                     172.60 | 166.93 | 308.10 | 149.78 | 153.91 | 
| Operating Income/Loss | 
                                            
                                        327.09%
                                     8.499 | 1.99 | -139.53 | 28.24 | 13.21 | 
| Nonoperating Income/Loss | 
                                            
                                        255.24%
                                     -10.43 | 6.716 | 0.671 | 8.344 | 0.428 | 
| Income/Loss From Continuing Operations Before Tax | 
                                            
                                        122.13%
                                     -1.927 | 8.706 | -138.86 | 36.58 | 13.64 | 
| Income Tax Expense/Benefit, Deferred | 
                                            
                                        46.17%
                                     0.752 | 1.397 | 1.115 | 12.54 | 3.463 | 
| Income Tax Expense/Benefit | 
                                            
                                        25.01%
                                     2.92 | 3.894 | 4.61 | 17.70 | 4.661 | 
| Income/Loss From Continuing Operations After Tax | 
                                            
                                        200.73%
                                     -4.847 | 4.812 | -143.47 | 18.89 | 8.979 | 
|  | 
                                            
                                        200.73%
                                     -4.847 | 4.812 | -143.47 | 18.89 | 8.979 | 
| Preferred Stock Dividends And Other Adjustments | - | - | - | - | - | 
| Attributable To Noncontrolling Interest | - | - | - | - | - | 
| Basic Average Shares | 
                                            
                                        1.76%
                                     45.46 | 46.27 | 46.13 | 46.17 | 46.50 | 
| Diluted Average Shares | 
                                            
                                        2.29%
                                     45.46 | 46.53 | 46.13 | 50.54 | 52.19 | 
| Basic Earnings Per Share | 
                                            
                                        210.00%
                                     -0.11 | 0.10 | -3.11 | 0.41 | 0.19 | 
| Diluted Earnings Per Share | 
                                            
                                        210.00%
                                     -0.11 | 0.10 | -3.11 | 0.39 | 0.19 | 
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | - | - | - | - | - | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App
                